Literature DB >> 18178814

Naive precursors of human regulatory T cells require FoxP3 for suppression and are susceptible to HIV infection.

Amanda K Antons1, Rui Wang, Kyra Oswald-Richter, Michelle Tseng, Christopher W Arendt, Spyros A Kalams, Derya Unutmaz.   

Abstract

CD4+CD25+ human regulatory T cells (Treg cells), which express the transcription factor FoxP3, suppress T cell activation. In this study, we sought to define cellular and molecular mechanisms of human Treg cell differentiation. A subset of human naive CD4+ T cells that are CD25+ express high levels of FoxP3. We show that upon activation through the TCR, these FoxP3-expressing naive T cells (termed TNreg cells) greatly expand in vitro. Expanded TNreg cells acquire a full Treg phenotype with potent suppressive activity and display low IL-2 production upon TCR stimulation. TNreg cells in which FoxP3 expression was reduced through RNA interference lost their suppressive activity, but retained their low IL-2 secretion in response to TCR stimulation. Furthermore, in support of the notion that TNreg cells represent a separate lineage of naive cells, we found that they were more susceptible to HIV infection as compared with naive CD4+ T cells. Based on these findings, we propose that TNreg cells are precursors for human Treg cells and that these cells require a high level of FoxP3 expression to maintain their suppressive function. Accordingly, modulation of TNreg cell numbers during infections such as HIV may disrupt human Treg cell development, and contribute to chronic immune activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18178814     DOI: 10.4049/jimmunol.180.2.764

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

1.  In vivo depletion of CD4(+)CD25(hi) regulatory T cells is associated with improved antiviral responses in cats chronically infected with feline immunodeficiency virus.

Authors:  S Rochelle Mikkelsen; Stacie K Reckling; Erin A Egan; Gregg A Dean
Journal:  Virology       Date:  2010-05-14       Impact factor: 3.616

2.  Differentiation of IL-17-producing effector and regulatory human T cells from lineage-committed naive precursors.

Authors:  Frances Mercer; Alka Khaitan; Lina Kozhaya; Judith A Aberg; Derya Unutmaz
Journal:  J Immunol       Date:  2014-06-23       Impact factor: 5.422

3.  Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells.

Authors:  Rui Wang; Lina Kozhaya; Frances Mercer; Alka Khaitan; Hodaka Fujii; Derya Unutmaz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-28       Impact factor: 11.205

4.  Early and long-lasting alteration of effector CD45RA(-)Foxp3(high) regulatory T-cell homeostasis during HIV infection.

Authors:  Federico Simonetta; Camille Lecuroux; Isabelle Girault; Cécile Goujard; Martine Sinet; Olivier Lambotte; Alain Venet; Christine Bourgeois
Journal:  J Infect Dis       Date:  2012-03-28       Impact factor: 5.226

5.  Regulatory T Cells Contribute to HIV-1 Reservoir Persistence in CD4+ T Cells Through Cyclic Adenosine Monophosphate-Dependent Mechanisms in Humanized Mice In Vivo.

Authors:  Guangming Li; Jun-Ichi Nunoya; Liang Cheng; Natalia Reszka-Blanco; Li-Chung Tsao; Jerry Jeffrey; Lishan Su
Journal:  J Infect Dis       Date:  2017-12-19       Impact factor: 5.226

6.  FOXP3 inhibits HIV-1 infection of CD4 T-cells via inhibition of LTR transcriptional activity.

Authors:  Nithianandan Selliah; Mingce Zhang; Sara White; Philip Zoltick; Bassel E Sawaya; Terri H Finkel; Randy Q Cron
Journal:  Virology       Date:  2008-10-01       Impact factor: 3.616

7.  ZNF9 activation of IRES-mediated translation of the human ODC mRNA is decreased in myotonic dystrophy type 2.

Authors:  Morgan A Sammons; Amanda K Antons; Mourad Bendjennat; Bjarne Udd; Ralf Krahe; Andrew J Link
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

8.  Increased sensitivity of CD4+ T-effector cells to CD4+CD25+ Treg suppression compensates for reduced Treg number in asymptomatic HIV-1 infection.

Authors:  Georgina Thorborn; Laura Pomeroy; Heidi Isohanni; Melissa Perry; Barry Peters; Annapurna Vyakarnam
Journal:  PLoS One       Date:  2010-02-17       Impact factor: 3.240

9.  Development and management of systemic lupus erythematosus in an HIV-infected man with hepatitis C and B co-infection following interferon therapy: a case report.

Authors:  Iain J Abbott; Christina C Chang; Matthew J Skinner; Alison Street; Greg Perry; Catriona McLean; Edwina J Wright; Paul U Cameron
Journal:  J Med Case Rep       Date:  2009-06-10

10.  Expression and function of TNF and IL-1 receptors on human regulatory T cells.

Authors:  Frances Mercer; Lina Kozhaya; Derya Unutmaz
Journal:  PLoS One       Date:  2010-01-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.